![]() |
E. Paul Larrat, Ph.D.
|
|
Research Interests |
Drug benefit design issues, formulary compliance strategies, pharmacoeconomic evaluation, decision analysis, outcomes assessment and drug utilization management. |
|
Education |
B.S. Pharmacy, University of Rhode Island, 1982 M.B.A., University of Rhode Island, 1984 M.S. Pharmacy Administration, University of Rhode Island, 1988 Ph.D. Epidemiology, Brown University, 1992 |
|
| Selected Publications | Larrat EP, Stutte G, Wheeler RM. Effect of biogenic compound production on human health in closed life support systems. National Aeronautics and Space Administration (Technical Report). Washington, DC, 2005. [under review] Abugosh SM, Kogut SJ, Andrade SE, Larrat EP, Gurwitz JH. Persistence with lipid-lowering therapy; Influence of the type of lipid-lowering agent and drug benefit plan option in elderly patients. Journal of Managed Care Pharmacy 2004; 10(5): 404-411. Kogut SJ, Andrade SE, Larrat EP, Willey C. The influence of nonadherence on changes in oral antidiabetic drug therapy. Pharmacoepidemiology and Drug Safety. 2004; 13:591-598. Dhall J, Larrat EP, Lapane KL. Use of potentially inappropriate drugs in nursing homes. Pharmacotherapy 2002, 22(1):88-96. Kogut S, Perfetto E, Larrat EP. United States regulation of health care economic data. In Vogenberg FR, editor. Introduction to applied pharmacoeconomics. New York: McGraw-Hill, 2000. Bayliss, M.S., Larrat, E.P., Buchner, D. and Ware, J.E. ITG-Asthma Short Form: Manual and Interpretation Guide. Lincoln, R.I.: QualityMetric Inc. :2000 . |
|